...
首页> 外文期刊>Journal of the American College of Cardiology >Comparison of gene delivery techniques for therapeutic angiogenesis ultrasound-mediated destruction of carrier microbubbles versus direct intramuscular injection.
【24h】

Comparison of gene delivery techniques for therapeutic angiogenesis ultrasound-mediated destruction of carrier microbubbles versus direct intramuscular injection.

机译:用于治疗性血管生成超声介导的载体微泡破坏与直接肌内注射的基因传递技术的比较。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVES: This study was designed to compare the efficacy of angiogenic gene delivery by ultrasound-mediated (UM) destruction of intravenous carrier microbubbles to direct intramuscular (IM) injections. BACKGROUND: Current trials of gene therapy for angiogenesis remain limited by suboptimal, invasive delivery techniques. METHODS: Hind-limb ischemia was produced by iliac artery ligation in 99 rats. In 32 rats, UM delivery of green fluorescent protein (GFP)/vascular endothelial growth factor-165 (VEGF(165)) plasmid deoxyribonucleic acid was performed. Thirty-five animals received IM injections of VEGF(165)/GFP plasmid. Remaining rats received no treatment. Before delivery (day 14 after ligation) and at days 17, 21, and 28 and week 8 after ligation, microvascular blood volume and microvascular blood flow to the proximal hind limbs were assessed by contrast-enhanced ultrasound (n = 8 per group). Total transfection was assessed by reverse transcriptase-polymerase chain reaction, and localization of transfection was determined by immunohistochemistry. RESULTS: By day 28, both IM and UM delivery of VEGF(165) produced significant increases in microvascular blood volume and microvascular blood flow. Whereas increases in microvascular blood volume were similar between treatment groups, microvascular blood flow was greater (p < 0.005) in UM-treated animals as compared with IM-treated animals, persisting to week 8. The VEGF(165)/GFP messenger ribonucleic acid expression was greater (p < 0.05) for IM-treated animals. A strong GFP signal was detected for both groups and was localized to focal perivascular regions and myocytes around injection sites for IM and to the vascular endothelium of arterioles/capillaries in a wider distribution for UM delivery. CONCLUSIONS: Despite lower transfection levels, UM delivery of VEGF(165) is as effective as IM injections. The UM delivery results in directed vascular transfection over a wider distribution, which may account for the more efficient angiogenesis.
机译:目的:本研究旨在比较通过超声介导(UM)破坏静脉内载体微泡与直接肌内(IM)注射产生血管生成基因的功效。背景:目前,针对血管生成的基因治疗的试验仍受到次优,侵入性递送技术的限制。方法:99只大鼠通过artery动脉结扎产生后肢缺血。在32只大鼠中,进行了UM递送绿色荧光蛋白(GFP)/血管内皮生长因子-165(VEGF(165))质粒脱氧核糖核酸。 35只动物接受IM注射的VEGF(165)/ GFP质粒。其余大鼠未接受治疗。分娩前(结扎后第14天)以及结扎后第17、21和28天以及第8周,通过对比增强超声(每组n = 8)评估微血管血流量和流向近端后肢的微血管血流量。通过逆转录酶-聚合酶链反应评估总转染,并通过免疫组织化学确定转染的定位。结果:到第28天,IM和UM的VEGF(165)递送均显着增加了微血管血容量和微血管血流量。尽管治疗组之间的微血管血流量增加相似,但与IM治疗的动物相比,UM治疗的动物的微血管血流量更大(p <0.005),持续到第8周。VEGF(165)/ GFP信使核糖核酸IM处理的动物的mRNA表达更高(p <0.05)。两组均检测到强GFP信号,并定位于局灶性血管周区域和IM注射部位周围的心肌细胞,以及更宽的UM递送分布于小动脉/毛细血管的血管内皮。结论:尽管转染水平较低,但VEGF(165)的UM递送与IM注射一样有效。 UM递送导致定向的血管转染在更广泛的分布上,这可以解释更有效的血管生成。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号